Non-Current Assets
Long- term Investments
Vertex Pharmaceuticals Long- term Investments increased by 0.7% to $5.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $5.16B to $5.75B. Over 3 years (FY 2022 to FY 2025), Long- term Investments shows an upward trend with a 270.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2022
Last reportedQ1 2026May 5, 2026
Metric ID:
non_current_assets_marketable_securities_noncurrentHistorical Data
14 periods
| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $112.20M | $1.08B | $1.36B | $1.70B | $2.50B | $4.38B | $4.39B | $4.70B | $5.11B | $5.16B | $5.65B | $5.72B | $5.71B | $5.75B |
| QoQ Change | — | +863.9% | +25.5% | +25.2% | +46.9% | +75.4% | +0.3% | +7.1% | +8.6% | +1.0% | +9.5% | +1.4% | -0.2% | +0.7% |
| YoY Change | — | — | — | — | >999% | +305.1% | +223.7% | +176.7% | +104.5% | +17.7% | +28.5% | +21.7% | +11.8% | +11.5% |
Range$112.20M – $5.75B
CAGR+235.8%
Avg YoY Growth+302.7%
Median YoY Growth+66.5%
Long- term Investments at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's long- term investments?
- Vertex Pharmaceuticals (VRTX) reported long- term investments of $5.75B in Q1 2026.
- How has Vertex Pharmaceuticals's long- term investments changed year-over-year?
- Vertex Pharmaceuticals's long- term investments increased by 11.5% year-over-year, from $5.16B to $5.75B.
- What is the long-term trend for Vertex Pharmaceuticals's long- term investments?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's long- term investments has grown at a 270.6% compound annual growth rate (CAGR), from $112.20M to $5.71B.